AHA: Patient Safety Better Than Pre-Pandemic
AHA’s new report shows hospital performance on safety measures and quality is better than it was pre-pandemic
Read More
Pear Suite Community Health Worker Network Expands
Over the past ten months, Pear Suite has partnered with seven health plans to recruit and onboard more than 1,000 community health workers
Some of the Biggest Healthcare Stories from 2024 Involved Pharmacy. What’s Next in 2025?
Regulators will have their work cut out for them under a new administration that has expressed an anti-regulatory preference. Republicans next year will control the White House, Senate and House. What will it all mean for pharmacy leaders? The post Some of the Biggest Healthcare Stories from 2024 Involved Pharmacy. What’s Next in 2025? appeared…
EHRs Are Overloading Mental Health Clinicians — Can AI Save the Day?
When AI is directly integrated into the EHR it not only improves efficiency but also ensures that patient data remains secure within the same trusted system. The post EHRs Are Overloading Mental Health Clinicians — Can AI Save the Day? appeared first on MedCity News.
AstraZeneca Turns to CSPC Pharma Again, Putting Up $110M to Start Multi-Drug R&D Pact
AstraZeneca’s R&D collaboration with CSPC Pharmaceutical Group includes an oral small molecule for immunological diseases, which would offer a dosing edge over currently available injectable medications. The agreement follows a 2024 licensing agreement that granted AstraZeneca rights to an oral CSPC drug candidate in development for a metabolic disorder. The post AstraZeneca Turns to CSPC…
Debunked Episode 29: CMS GLP-1 Drug Pilot Program, RPM Strategy Raise Questions
At MedCity News’ inaugural Bullseye conference in Chicago, Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed recent CMS actions and Mayo Clinic’s former research director, who has filed a complaint against the medical center over how it’s deploying AI. The post Debunked Episode 29: CMS GLP-1 Drug Pilot Program, RPM Strategy Raise Questions appeared…
Las vacunas ayudan a las personas mayores más de lo que se pensaba
Seamos claros. La razón principal para vacunarse contra la culebrilla (shingles, la infección que genera el virus herpes zóster) es que dos dosis brindan una protección del 90% contra una enfermedad dolorosa, que produce ampollas y puede causar dolor nervioso persistente y otras complicaciones graves a largo plazo. Y que afectará a un tercio de…
From Products to Services: How Medical Device Companies Miss $100M+ Opportunities
As trends around expanded decision-making ecosystems, consumer empowerment, data and intelligence, and economic uncertainty become everyday realities, the need for medical device companies to rethink and expand their business models becomes more urgent. The post From Products to Services: How Medical Device Companies Miss $100M+ Opportunities appeared first on MedCity News.
Lōvu Health Rakes In $8M for Maternal Health Platform
Lōvu Health’s Series A round was led by SJF Ventures and included participation from Rogue Women’s Fund, Symphonic Capital, Emmeline Ventures and Majella Ventures. The post Lōvu Health Rakes In $8M for Maternal Health Platform appeared first on MedCity News.
Cáncer de mama y anticonceptivos: un nuevo estudio revela cómo se puede distorsionar la ciencia
Mientras la desinformación sobre la salud de las mujeres se propaga más rápido que nunca, médicos dicen que una nueva investigación sobre los riesgos de los anticonceptivos hormonales pone en evidencia los desafíos de comunicar con matices en la era de las redes sociales. El extenso estudio, realizado en Suecia, siguió a más de 2…